BACKGROUND: Public health interventions that prevent mortality and morbidity have greatly
increased over the past decade. Immunization is one of these preventive interventions, with …

Background Most health economic evaluations of childhood vaccination only capture the
health and short-term economic benefits. Measuring broader, long-term effects of …

Hepatitis A is an important public health issue worldwide. Hepatitis A vaccine (HepA) was
first licensed in 1992. Both inactivated HepA (HepA-I) and live attenuated HepA (HepA-L) …

Background: Hepatitis A vaccines have been highly effective in preventing hepatitis A. To
investigate the epidemiology of hepatitis A in China after hepatitis A vaccine became …

Background: After a country wide outbreak occurred during 2003–2004, 1 dose of hepatitis
A vaccine was introduced into Argentinian regular immunization schedule for all children …

Objective The objectives of this review were to identify vaccine economic evaluations that
include herd immunity and describe the methodological approaches used. Methods We …

For the first time a global meeting on hepatitis A virus (HAV) infection as vaccine preventable
disease was organized at the end of 2007. More than 200 experts from 46 countries …

The World Health Organization (WHO) recommends the consideration of introducing routine
hepatitis A vaccination into national immunization schedules for children≥ 1 years old in …

OBJECTIVE: To conduct a cost-effectiveness analysis of a universal childhood hepatitis A
vaccination program in Brazil. METHODS: An age and time-dependent dynamic model was …

Background This study aimed to identify the transmission pattern of hepatitis A (HA) infection
based on a primary dataset from the Brazilian National Hepatitis Survey in a pre-vaccination …